Dealing with difficulties in speech and communication can be very frustrating, especially when it’s due to a rare condition like fucosidosis, which can make managing speech and communication issues particularly challenging. Read on to learn more about the effects of fucosidosis on speech and language.
What is fucosidosis?
Fucosidosis is a rare genetic lysosomal storage disorder that affects the body’s ability to break down certain complex sugars. This happens due to mutations or changes in the FUCA1 gene which results in a deficiency of the enzyme alpha-L-fucosidase. This enzyme is needed to break down these sugars in the body’s cells, so when it doesn’t work properly, sugars build up in the cells and cause damage over time. To develop fucosidosis, both parents need to carry a copy of the faulty FUCA1 gene. This condition is extremely rare, affecting about 1 in 200,000 births worldwide. However, it is more common in some places like Southern Italy, Cuba, Tunisia, and some communities in the United States.
Types of fucosidosis
There is some debate about whether fucosidosis should be classified into two distinct types or if it is considered a variation of the same disorder with different levels of severity. However, it is generally classified into two types based on how severe the symptoms are and the age at which they first appear:1
- Type 1 (More severe): Symptoms usually begin within the first six months of life. This form involves rapid neurological deterioration, leading to severe disability, and often leads to early childhood death
- Type 2 (Milder form): Symptoms develop later around 18 months to two years with slower progression often allowing for a longer lifespan
What does fucosidosis look like?
People with fucosidosis may have a variety of symptoms, which can vary in severity, such as:2
- Skin: Small, red or purple bumps and widespread skin changes such as thickening and unusual sweating
- Eyes: Dilated and twisted blood vessels in the eyes, which may affect vision
- Facial features: Coarse facial features and often shorter stature
- Heart: Mild heart issues like valve problems and potential enlargement
- Respiratory system: Frequent respiratory infections and breathing difficulties
- Liver and spleen: Possible enlargement of the liver and spleen
- Bones and joints: Abnormal bone growth and joint issues
- Neurological and cognitive function: Progressive loss of cognitive and motor skills including difficulty walking, speaking, and performing daily activities
What is the impact of fucosidosis on speech and language development?
People with fucosidosis often have delayed development and deterioration of motor skills such as walking. They also suffer from general slowing of cognitive functions, including thought processing, movement, and speech. The buildup of sugars in the brain contributes to learning difficulties that vary in severity in children and adolescents. One study reviewed data from 77 patients with fucosidosis and found that many lost the ability to sit, stand, or walk, with 67% losing the ability to speak. They found that 28% of patients experienced rapid neurological decline, losing all abilities before age five, while others had a slower progression, keeping some motor and speech skills into their teenage years.3
Fucosidosis can affect speech and language in several ways, including:
- Difficulty understanding and using words: Individuals with fucosidosis often struggle with verbal comprehension and reasoning. For example, in a study, a 22-year-old woman could recognise basic categories like "animals" but had difficulty understanding more abstract ones, such as grouping "ice cream" and "chocolate" as "sweets"4
- Severe delays in language skills: Many children with fucosidosis experience significant delays in language skills. An 8-year-old boy could only spell basic words, while another child lost the ability to speak entirely by age two5
- Progressive loss of speech abilitiesThe progression of the disease can also lead to the deterioration of previously acquired language skills. For instance, by age 12, one patient had lost the ability to talk entirely. Moreover, in another study, one patient was able to say only a few single words by 18 months, and by 2 years, he did not speak at all6
What are the causes of speech and language impairments in fucosidosis?
Although the literature does not directly discuss the causes, it is possible to infer that communication difficulties in fucosidosis might be due to several underlying factors, such as:
- Neurological damage: The accumulation of complex sugars in the brain leads to progressive neurological damage, which can directly affect areas responsible for speech and language processing. Brain scans of patients with fucosidosis, such as a 2-year-old boy, have shown damage or swelling in the globus pallidus, a brain region that helps control movement. This damage, likely caused by the buildup of sugars, interferes with the muscle coordination needed for clear speech, leading to speech difficulties7
- Iron Deposition and damage: Magnetic Resonance Imaging (MRI) scans of patients aged 3.5 and 7 years have revealed decreased signals in the globus pallidus and substantia nigra (A key part of the brain that produces dopamine) which suggests iron buildup. This iron deposition, potentially due to brain damage or oxygen deprivation, may contribute to difficulties with speech and movement control7
- White matter changes: Abnormal signals in the white matter are noted in several patients. These changes could suggest problems with myelination, the process that helps nerve cells communicate efficiently. When myelination is disrupted, it can affect the brain pathways needed for speech, language, and thinking, causing communication difficulties7
- Nerve cell loss: Nerve cell loss in critical areas like the thalamus, hypothalamus, cerebral cortex, and Purkinje cells—which are essential for understanding and producing language-occurs in fucosidosis. The loss of neurons in these regions disrupts the brain's communication pathways, leading to difficulties in speaking, understanding language, and overall communication7
- Physical challenges: Physical traits common in fucosidosis, such as a protruding tongue, can interfere with clear speech, making communication difficult6
- Severe cognitive impairments: Profound intellectual disabilities, with some individuals having IQs below 35, can severely hinder language development and communication6
What are the treatment options?
Treatment for fucosidosis aims to manage each person's unique symptoms. For example, antibiotics may be given for frequent infections, and fluids might be provided to address dehydration from excessive sweating. Comprehensive care often involves a team of specialists to offer medical services and social support. Genetic counselling is also suggested for those affected and their families.
Some potential treatments include:
- Enzyme replacement therapy (ERT): ERT for fucosidosis is in preclinical testing, delivering a recombinant enzyme to the central nervous system. Animal studies show partial improvement, but a more intensive approach may be needed for better results2
- Stem cell and bone marrow transplantation: Hematopoietic stem cell transplantation (HSCT) has shown promise in animals and some success in humans, especially when done early. It can stabilize symptoms and improve enzyme levels, though it doesn’t prevent brain damage.2 Bone marrow transplants (BMT) can improve physical abilities like movement, especially when done early in life. These treatments may enhance overall neurological health, potentially reducing communication difficulties
- Gene therapy: Gene therapy is being studied as a potential treatment but has not yet been tested in clinical trials2
What kind of therapy helps communication and speech difficulties?
Given the impact of speech and language impairments on people. It is important to provide appropriate support and interventions to help them communicate as effectively as possible.
Speech therapy involves a variety of techniques depending on the specific speech or language disorder. Treatment usually involves multiple sessions, each lasting 30 to 60 minutes. These sessions can be one-on-one or in groups.
Common methods include:
- Perception Exercises: Recognizing different sounds and syllables
- Speech Exercises: Producing specific sounds and improving fluency
- Voice and Breathing Activities: Enhancing breathing, swallowing, and voice control
- Communication Tools: Using sign language, communication boards, or speech devices
- Guidance: Offering advice for patients, families, and caregivers
- Practical Strategies: Applying techniques in daily life
Regular practice at home is crucial for progress. Speech therapy can be found at clinics, rehabilitation centres, special needs schools, and daycare facilities. Other specialists may also use similar methods.
Additional resources for those with fucosidosis
- Clinical trials: To find the latest UK-based clinical trials, visit Be Part of Research. For international trials, check ClinicalTrials.gov.These resources provide details on the status of trials, including whether they are recruiting, completed, or withdrawn, as well as their locations around the world. For information on past or current trials, consult your doctor to understand the associated risks and benefits
- Information Centers: The Genetic and Rare Diseases Information Center (GARD) provides detailed resources about fucosidosis, including general information about the condition, its symptoms, and potential management strategies
- Patient support and advocacy: Support organizations like the National Organization for Rare Disorders (NORD) offer resources, guidance, and advocacy support for individuals with fucosidosis and their families. These organizations help connect patients to clinical trials, provide educational materials, and advocate for rare disease research and support
Summary
Fucosidosis is a rare genetic disorder affecting sugar breakdown due to a deficiency in the enzyme alpha-L-fucosidase, leading to cell damage. It is extremely rare but more common in specific regions. The condition is often classified into two types: Type 1, which presents severe symptoms early in life and can lead to early death, and Type 2, which is milder and progresses more slowly. This disorder impacts speech and language development, causing delays and progressive loss of communication skills. Treatments focus on managing symptoms, such as enzyme replacement therapy and stem cell transplantation, with ongoing research into gene therapy. For more information and resources, people can consult specialized websites and support organizations.
References
- Kaur A, Dhaliwal AS, Raynes H, Naidich TP, Kaufman DM. Diagnosis and Supportive Management of Fucosidosis: A Case Report. Cureus [Internet]. 2019 [cited 2024 Sep 1].Available from:https://www.cureus.com/articles/21783-diagnosis-and-supportive-management-of-fucosidosis-a-case-report.
- Stepien KM, Ciara E, Jezela-Stanek A. Fucosidosis—Clinical Manifestation, Long-Term Outcomes, and Genetic Profile—Review and Case Series. Genes [Internet]. 2020 [cited 2024 Sep 1]; 11(11):1383. Available from: https://www.mdpi.com/2073-4425/11/11/1383.
- Willems PJ, Gatti R, Darby JK, Romeo G, Durand P, Dumon JE, et al. Fucosidosis revisited: A review of 77 patients. Am J Med Genet [Internet]. 1991 [cited 2024 Aug 25]; 38(1):111–31. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajmg.1320380125.
- Puente-Ruiz N, Ellis I, Bregu M, Chen C, Church HJ, Tylee KL, et al. Long-term outcomes in two adult siblings with Fucosidosis – Diagnostic odyssey and clinical manifestations. Molecular Genetics and Metabolism Reports [Internet]. 2023 [cited 2024 Aug 25]; 37:101009. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2214426923000551.
- Wang L, Yang M, Hong S, Tang T, Zhuang J, Huang H. Fucosidosis in a Chinese boy: a case report and literature review. J Int Med Res [Internet]. 2020 [cited 2024 Aug 25]; 48(4):030006052091126. Available from: http://journals.sagepub.com/doi/10.1177/0300060520911269.
- Landing BH, Donnell GN, Alfi OS, Neustein HB, Lee FA, Ng WG, et al. Fucosidosis: Clinical, Pathologic, and Biochemical Studies of Five Patients. In: Volk BW, Schneck L, editors. Current Trends in Sphingolipidoses and Allied Disorders [Internet]. Boston, MA: Springer US; 1976 [cited 2024 Sep 2]; bk. 68, p. 147–65. Available from: http://link.springer.com/10.1007/978-1-4684-7735-1_10.
- Terespolsky D, Clarke JTR, Blaser SI. Evolution of the neuroimaging changes in fucosidosis type II. J of Inher Metab Disea [Internet]. 1996 [cited 2024 Aug 25]; 19(6):775–81. Available from: https://onlinelibrary.wiley.com/doi/10.1007/BF01799172.

